Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lisa D. Volk"'
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 13, Iss 4, Pp 327-338 (2011)
Introduction Patients with metastatic disease are considered incurable. We previously showed that nabpaclitaxel (nanoparticle albumin-embedded paclitaxel) combined with anti-vascular endothelial growth factor A (VEGF-A) antibody, bevacizumab, eradica
Externí odkaz:
https://doaj.org/article/6eabd8898199407cb0ad7a587ba3b28c
Autor:
Lisa D. Volk, Michael J. Flister, Christopher M. Bivens, Alan Stutzman, Neil Desai, Vuong Trieu, Sophia Ran
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 10, Iss 6, Pp 613-623 (2008)
Nab-paclitaxel is an albumin-bound 130-nm particle form of paclitaxel that has shown an improved efficacy in experimental tumor models and clinical studies compared with solvent-based paclitaxel. Anti–vascular endothelial growth factor A (VEGF-A) a
Externí odkaz:
https://doaj.org/article/3ced551fc7fc4bcc973831ee7cc5f472
Supplementary Figure Legends - PDF file 88K, Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42f9e76bb8287283e6a426b5d2ca5f33
https://doi.org/10.1158/1535-7163.22500054.v1
https://doi.org/10.1158/1535-7163.22500054.v1
Overexpression of Toll-like receptor-4 (TLR4) in human tumors often correlates with chemoresistance and metastasis. We found that TLR4 is overexpressed in the majority of clinical breast cancer samples and in 68% of the examined breast cancer lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73677f479852999a1710e77769e903be
https://doi.org/10.1158/1535-7163.c.6536334
https://doi.org/10.1158/1535-7163.c.6536334
Supplementary Figure S2 - PDF file 188K, Expression of TLR receptors in MDA-MB-231 and HCC1806 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2f4e32e39a6ea88ead64f04e3f286c
https://doi.org/10.1158/1535-7163.22500048.v1
https://doi.org/10.1158/1535-7163.22500048.v1
Supplementary Tables from TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Supplementary Tables - PDF file 134K, Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301fc5ef694b5b99659cf5f0ee95db7a
https://doi.org/10.1158/1535-7163.22500039.v1
https://doi.org/10.1158/1535-7163.22500039.v1
Publikováno v:
Cancer Research. 79:1506-1506
Introduction: Lymph node (LN) metastasis, a key prognostic factor for poor survival of breast cancer (BC) patients, directly depends on tumor lymphangiogenesis. We previously showed in orthotopic BC models that lymphangiogenesis is strongly promoted
Autor:
Lisa D. Volk-Draper, Sophia Ran
Publikováno v:
Cancer Research. 79:1967-1967
Introduction: Lymph node metastasis is the main prognostic indicator for poor survival of breast cancer patients. Metastasis is promoted by tumor-induced lymphangiogenesis mediated, in part, through recruitment of myeloid-derived lymphatic endothelia
Publikováno v:
Microcirculation (New York, N.Y. : 1994). 18(2)
Inflammation and NF-κB are highly associated with lymphangiogenesis but the underlying mechanisms remain unclear. We recently established that activated NF-κB p50 subunit increases expression of the main lymphangiogenic mediators, VEGFR-3 and its t
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179257 (2017)
Myeloid-derived lymphatic endothelial cells (M-LECP) are induced by inflammation and play an important role in adult lymphangiogenesis. However, the mechanisms driving M-LECP differentiation are currently unclear. We previously showed that activation
Externí odkaz:
https://doaj.org/article/10916262055046fc805b54ac26d4bad3